Claudio Vernieri, M.D. Ph.D., specialized in Clinical Oncology and Cancer Metabolism. Since January 2020 he directs the Metabolic Reprogramming in Solid Tumors program at IFOM, and works as a medical oncologist in the Breast Unit of Fondazione IRCCS Istituto Nazionale dei Tumori. read more
Contact the researcherWhen compared to normal cells, cancer cells are characterized by unrestrained growth and proliferation, which are sustained by an increased uptake, biosynthesis or catabolism of crucial metabolites, including glucose, amino acids, nucleotides and fatty acids.read more
libero.it